Tend Funding, Investors & Competitors

Tend has raised $198M across 4 funding rounds, most recently a $125M Series C in April 2021.

See full Tend profile

Last Tend funding round

$125M

Series C · Apr 2021

Cumulative funding Tend raised

$198M

across 4 funding rounds

Key investors in Tend

  • Juxtapose
  • Redpoint
  • GV
  • Tusk Venture Partners
  • Zigg Capital
  • Tiger Global
  • Addition
  • Good Friends

Tend Overview

About Tend

Tend is a New York-headquartered dental practice chain transforming patient care with tech-enabled studios in New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Launched in 2019, it operates 25 locations emphasizing same-day appointments, digital scans, and hospitality design. Tend employs over 650 staff providing general, cosmetic, and orthodontic services.


Founded

2018

HQ

United StatesNashville, TN

Status

Privately held

Customer focus

B2C

Revenue model

Services

Tend Funding History

Tend has raised a total of $198M across 4 funding rounds.

Tend's first fundraising round was a $16M seed round in October 2019. The most recent completed round was a $125M Series C in April 2021.

Tend funding rounds

Tend funding rounds
DateStageInvestorsRaisedDeal Summary
Apr 2021Series CAddition (lead); Redpoint; GV; Zigg Capital; Juxtapose; Montauk Ventures$125M-
Oct 2020Series BGV (lead); Redpoint; Good Friends; Zigg Capital; Juxtapose; Tiger Global$37MTend is a digital health company that raised $270.23M across multiple funding rounds. Tend's most recent disclosed funding was a Series D round of $72.23M on August 9, 2024, led by Addition with participation from Google Ventures, Juxtapose, Plum Alley, and Redpoint Ventures. The company has raised capital from prominent investors including Google Ventures (now Google Ventures), demonstrating investor confidence in the digital health sector.
Oct 2019Series ARedpoint (lead); Tusk Venture Partners; Juxtapose; Flatiron Health; Warby Parker; Oxeon Partners; Amazon One Medical$21MTend is a New York City-based dental startup offering services like cleanings, X-rays, and wisdom-tooth extractions at clinics, primarily serving patients with dental insurance. It launched in October 2019 and has raised approximately $200 million total by 2021 across multiple rounds, including a Series B of $44 million in October (likely 2020) and a Series C of $125 million in 2021 led by Addition with participation from GV, Juxtapose, Redpoint, and Zigg Capital. Tend operated six clinics in New York City by 2021, with plans for a seventh, aiming for 20 locations by end-2021 including Washington, DC, and Boston, and 75 clinics in top 20 metros by 2023. During the 2020 pandemic, it closed clinics for three months but recovered to 85% of pre-pandemic revenue levels. It served about 20,000 patients and planned direct-to-consumer oral-health products like electric toothbrushes. Total funding reached $270.23 million over five rounds by 2024 with 15 investors.
Oct 2019SeedJuxtapose (lead); Tusk Venture Partners$16MTend is a dental care startup that provides hassle-free, personalized dentistry services in modern studios, founded in October 2019 by Doug Hudson, Andy Grover, and Michael Stenclik. It operates studios in New York locations including Chelsea, Flatiron, Grand Central, Wall Street, and Williamsburg, focusing on patient happiness through technology and design. In October 2019, Tend raised $15.5 million in a seed round led by Juxtapose, with participation from Tusk Venture Partners among its backers, to launch operations. The company was not yet profitable in 2019, when revenue exceeded $5 million. Tend continued fundraising with a $20.5 million Series A also in October 2019 led by Redpoint, bringing total capital to over $73 million by its $37 million Series B in October 2020 led by Google Ventures, with Juxtapose and Redpoint participating alongside Tiger Global, Zigg Capital, and Good Friends. The Series B funded expansion to over 20 studios starting with Boston and Washington DC in 2021, plus new oral care products. Amid COVID-19, Tend recovered strongly, with new patient appointments at 85% and revenue over 150% post-reopening.

Who has invested in Tend?

13 investors have backed Tend across its funding rounds, including Juxtapose, Redpoint, GV, Tusk Venture Partners, Zigg Capital and Tiger Global.

Lead investors include Addition, GV, Redpoint and Juxtapose.


Tend Investors

Investors in Tend by funding rounds participated
InvestorHQRoundsRoleFirst check
JuxtaposeUnited StatesNew York City, NY4LeadOct 2019
RedpointUnited StatesSan Francisco, CA3LeadOct 2019
GVUnited StatesSan Francisco, CA2LeadOct 2020
Tusk Venture PartnersUnited StatesNew York City, NY2ParticipantOct 2019
Zigg CapitalUnited StatesNew York City, NY2ParticipantOct 2020
Good FriendsUnited StatesUnited States1ParticipantOct 2020
AdditionUnited StatesUnited States1LeadApr 2021
Flatiron HealthUnited StatesNew York City, NY1ParticipantOct 2019
Warby ParkerUnited StatesNew York City, NY1ParticipantOct 2019
Tiger GlobalUnited StatesNew York City, NY1ParticipantOct 2020
Montauk VenturesUnited StatesNew York City, NY1ParticipantApr 2021

This data is available for Pro users. Sign up to see all 13 Tend investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Tend Competitors

Tend competitors include listed companies like HCA Healthcare, Alcon, Fresenius and Dr. Sulaiman Al Habib, and private ones like IVC Evidensia and Luz Saude.

Public and private companies comparable to Tend
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
HCA HealthcareUnited StatesUnited StatesPublicly listed$76B$16B$93B1.9x
AlconSwitzerlandSwitzerlandPublicly listed$10B$2.6B$31B3.3x
FreseniusGermanyGermanyPublicly listed$26B$4.2B$30B1.6x
Dr. Sulaiman Al HabibSaudi ArabiaSaudi ArabiaPublicly listed$3.7B$927M$21B5.9x
IVC EvidensiaUnited KingdomBristolPrivate--$14B-
Luz SaudePortugalLisbonPrivate-$333M$3.2B-

Tend Public Comps

Tend is still privately-owned, but its public comps include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, Tenet Healthcare, IHH Healthcare, Rede D'Or São Luiz, Apollo Hospitals, Encompass Health and DaVita.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
HCA Healthcare$76B$16B1.9x1.9x9.4x9.4x
Alcon$10B$2.6B3.4x3.3x13.4x12.5x
Fresenius$26B$4.2B1.6x1.6x10.1x9.4x
Dr. Sulaiman Al Habib$3.7B$927M6.4x5.9x25.2x24.7x
Tenet Healthcare$21B$4.5B1.7x1.6x8.1x7.5x
IHH Healthcare$6.3B$1.5B3.3x3.0x13.8x13.6x
Rede D'Or São Luiz$11B$1.3B1.7x1.6x14.3x8.4x
Apollo Hospitals$2.6B$398M5.3x4.9x34.9x32.1x

This data is available for Pro users. Sign up to see all Tend competitors and their valuation data.

Start Free Trial

Common questions about Tend

When was Tend founded?Tend was founded in 2018.
Where is Tend headquartered?Tend is headquartered in Nashville, TN, United States.
Is Tend publicly listed?No, Tend is a private, VC-backed company.
How much funding has Tend raised?Tend has raised $198M across 4 funding rounds.
What was Tend's last funding round?Tend's last funding round was a $125M Series C in April 2021, led by Addition.
Who are Tend's investors?Tend's investors include Juxtapose, Redpoint, GV, Tusk Venture Partners, Zigg Capital, Good Friends, Addition, Flatiron Health, Warby Parker, Tiger Global and 3 others.
Which companies are comparable to Tend?Companies comparable to Tend include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, IVC Evidensia and Luz Saude.

See companies similar to Tend

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial